Shares of Exelixis (EXEL -13%) were hammered today after the biotech firm announced plans to...
Shares of Exelixis (EXEL -13%) were hammered today after the biotech firm announced plans to hold back-to-back public offerings. It plans to offer, subject to market conditions, 20M common shares and an aggregate $225M of convertible senior subordinated notes due in 2019.
From other sites
at Zacks.com (Mar 18, 2015)
at Zacks.com (Feb 27, 2015)
at Zacks.com (Feb 23, 2015)
at Benzinga.com (Feb 5, 2015)
at CNBC.com (Dec 8, 2014)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs